Skip to content

Tools4Patient: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Tools4Patient

BE 0534.842.954
NACE 72.200, Scientific research and development
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€3.7m
2024 · -€2.9m-€813,398
Equity
€19.5m
2024 · €17.4m+€2.1m
Cash
€622,507
2024 · €491,612+€130,895
Balance sheet total
€23.1m
2024 · €22.0m+€1.2m

Largest movements

2024 to 2025
Assets
  • Current investments +€600,000

    new in 2025: €600,000

  • Intangible fixed assets +€531,463

    up €531,463 (+2.5%), from €21.1m to €21.6m

Equity and liabilities
  • Contributions +€6.0m

    up €6.0m (+25.7%), from €23.4m to €29.4m

  • Profit (loss) carried forward -€3.7m

    down €3.7m (-48.4%), from -€7.7m to -€11.5m

  • Debts after one year -€747,966

    down €747,966 (-24.4%), from €3.1m to €2.3m

    of which Financial debts: -€677,084

Income statement
  • Gross operating margin -€1.3m

    down €1.3m, from €825,540 to -€431,027

  • Financial charges -€180,202

    down €180,202 (-63.3%), from €284,870 to €104,668

  • Depreciation +€165,741

    up €165,741 (+13.8%), from €1.2m to €1.4m

  • Staff costs +€108,160

    up €108,160 (+5.6%), from €1.9m to €2.0m

  • Financial income -€98,941

    down €98,941 (-33.1%), from €298,798 to €199,857

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€2.9m
Gross operating margin -€1.3m
Staff costs -€108,160
Depreciation -€165,741
Write-downs -€945
Other operating charges +€16,546
Other operating items +€620,208
Financial income -€98,941
Financial charges +€180,202
Result 2025 -€3.7m
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€2.5m
Investment -€2.5m
Financing +€5.1m
Cash 2024 €491,612
Net result for the year -€3.7m
Depreciation +€1.4m
Receivables within one year +€62,653
Deferred charges and accrued income +€20,986
Smaller working-capital items -€5,546
Tax, wage and social debts -€220,807
Investment in fixed assets (net) -€1.9m
Current investments -€600,000
Debts after one year -€747,966
Current portion of long-term debt +€15,144
Contributions, distributions and other +€5.9m
Cash 2025 €622,507
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €21,971,367 €23,126,907 +€1.2m +5.3%
Fixed assets 21/28 €21,173,054 €21,681,339 +€508,285 +2.4%
Intangible fixed assets 21 €21,053,185 €21,584,648 +€531,463 +2.5%
Tangible fixed assets 22/27 €117,541 €94,428 -€23,113 -19.7%
Furniture and vehicles 24 €27,736 €20,420 -€7,316 -26.4%
Other tangible fixed assets 26 €89,806 €74,009 -€15,797 -17.6%
Financial fixed assets 28 €2,328 €2,263 -€65 -2.8%
Current assets 29/58 €798,313 €1,445,569 +€647,256 +81.1%
Amounts receivable within one year 40/41 €179,778 €117,125 -€62,653 -34.9%
Trade receivables 40 €108,618 €54,195 -€54,423 -50.1%
Other amounts receivable 41 €71,160 €62,930 -€8,230 -11.6%
Current investments 50/53 - €600,000 +€600,000
Cash at bank and in hand 54/58 €491,612 €622,507 +€130,895 +26.6%
Deferred charges and accrued income 490/1 €126,923 €105,937 -€20,986 -16.5%
Total equity and liabilities 10/49 €21,971,367 €23,126,907 +€1.2m +5.3%
Equity 10/15 €17,365,397 €19,480,111 +€2.1m +12.2%
Contributions 10/11 €23,359,852 €29,359,852 +€6.0m +25.7%
Capital 10 €23,359,852 €29,359,852 +€6.0m +25.7%
Issued capital 100 €23,359,852 €29,359,852 +€6.0m +25.7%
Profit (loss) carried forward 14 -€7,742,946 -€11,490,819 -€3.7m -48.4%
Investment grants 15 €1,748,491 €1,611,078 -€137,413 -7.9%
Amounts payable 17/49 €4,605,970 €3,646,796 -€959,174 -20.8%
Amounts payable after more than one year 17 €3,064,552 €2,316,586 -€747,966 -24.4%
Financial debts 170/4 €1,151,209 €474,125 -€677,084 -58.8%
Other amounts payable 178/9 €1,913,343 €1,842,461 -€70,882 -3.7%
Amounts payable within one year 42/48 €1,438,871 €1,235,805 -€203,065 -14.1%
Current portion of amounts payable after more than one year 42 €732,821 €747,966 +€15,144 +2.1%
Trade debts 44 €210,350 €212,947 +€2,597 +1.2%
Suppliers 440/4 €210,350 €212,947 +€2,597 +1.2%
Taxes, remuneration and social security 45 €495,699 €274,893 -€220,807 -44.5%
Remuneration and social security 454/9 €495,699 €274,893 -€220,807 -44.5%
Accrued charges and deferred income 492/3 €102,547 €94,405 -€8,143 -7.9%
Non-recurring operating income 76A €3,500 - -€3,500
Remuneration, social security and pensions 62 €1,934,610 €2,042,770 +€108,160 +5.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,201,648 €1,367,389 +€165,741 +13.8%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€945 - +€945
Other operating charges 640/8 €18,421 €1,875 -€16,546 -89.8%
Non-recurring operating charges 66A €620,208 - -€620,208
Gross operating margin 9900 €825,540 -€431,027 -€1.3m
Operating profit (loss) 9901 -€2,948,403 -€3,843,061 -€894,659 -30.3%
Financial income 75/76B €298,798 €199,857 -€98,941 -33.1%
Recurring financial income 75 €298,798 €199,857 -€98,941 -33.1%
Financial charges 65/66B €284,870 €104,668 -€180,202 -63.3%
Recurring financial charges 65 €284,870 €104,668 -€180,202 -63.3%
Profit (loss) for the period before taxes 9903 -€2,934,475 -€3,747,873 -€813,398 -27.7%
Profit (loss) for the period 9904 -€2,934,475 -€3,747,873 -€813,398 -27.7%
Profit (loss) for the period to be appropriated 9905 -€2,934,475 -€3,747,873 -€813,398 -27.7%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.